Applications for SfN's Early Career Policy Ambassadors (ECPA) Program are now open! Undergraduate, post-baccalaureate, graduate students, and recent PhD/MD recipients are encouraged to apply to this 10-month program. ECPA allows early career scientists to enhance their advocacy skills with the neuroscience community, policymakers, and the public. Ambassadors gain essential skills to advocate for science and encourage those in their networks to join the conversation. Apply by Wednesday, Jan. 3, 2024.
Last month, SfN held its annual meeting in Washington, D.C., and hosted many impactful advocacy events. Several of the current Early Career Policy Ambassadors presented their advocacy and policy work to meeting attendees during the Saturday evening poster session. Additionally, the Animals in Research Panel consisted of an expert panel and a patient advocate who shared the successes of animal research and what to expect in the future. Finally, the Advocacy forum was held as a congressional briefing on Capitol Hill about the latest research in post-traumatic stress disorder (PTSD) and how Congress can play a role. Congressman Earl Blumenauer (D-OR) and Congressman Morgan Luttrell (R-TX), the co-chairs of the Congressional Neuroscience Caucus, joined the briefing and provided remarks about the importance of PTSD neuroscience research. Read more in an article covering the briefing from the Medical University of South Carolina. We look forward to continuing hosting these important events at Neuroscience 2024 in Chicago.
Lead, collaborate, and inspire in the field of neuroscience. SfN members can nominate themselves or fellow colleagues, who are in good standing, for an Officer, councilor, or committee position. These positions are a fantastic way to get involved and volunteer with SfN. Submit before Friday, Feb. 2, 2024.
On November 15, Congress passed a tiered CR (H.R. 6363), averting a government shutdown. The laddered CR will extend government funding to Friday, Jan. 19, 2024, for four appropriations bills and Friday, Feb. 2, 2024, for the eight remaining bills, including Labor-HHS and CJS. There is not expected to be any movement on these bills until Congress returns from the holiday recess. Although SfN was happy to see a shutdown averted, it is still critical to keep in mind the negative impacts a CR has on biomedical research. These effects include delayed funding for necessary services and stress the importance of completing full-year appropriations.
Recently, the Senate confirmed Monica Bertagnolli, MD, to be the next director of NIH in a bipartisan 62-36 vote. Bertagnolli is the 17th person, the second woman, and the first surgeon to hold the position. She transitioned from her role as the 16th director of the National Cancer Institute, a position she had held since October 2022. SfN is pleased NIH now has a Senate-confirmed director for the first time since December 2021.
A recent Washington Post articleregarding cephalopods (specifically octopuses) mentioned how NIH is considering granting cephalopods used in research some protections given to nonhuman primates and other vertebrates. NIH released arequest for information (RFI)calling for comments on the regulation of cephalopods as laboratory animals. NIH notes that currently in the U.S. cephalopods are not regulated under the Animal Welfare Act and the Animal Welfare Regulations and are not included in the Public Health Service Policy on Human Care and Use of Laboratory Animals Policy. NIH also notes that the U.S. Government PrinciplesII, III, IV and IXoutline practices that can be applied to this class of animals despite the current gaps in knowledge. Share comments usingthis formby Friday, December 22.